aluates Reports

$ 0.0

Automative

Global and India Pneumococcal Vaccine Market Report & Forecast 2023-2029

Published Date: November 2023

Report Code: QYRE-Auto-25P15672

BUY CHAPTERS

Global and India Pneumococcal Vaccine Market Report & Forecast 2023-2029

Code: QYRE-Auto-25P15672

Report

November 2023

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

and India Pneumococcal Vaccine Market Size

The global Pneumococcal Vaccine revenue was US$ 7200.2 million in 2022 and is forecast to a readjusted size of US$ 7780.4 million by 2029 with a CAGR of 1.1% during the forecast period (2023-2029).

and India Pneumococcal Vaccine Market

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

In India, the Pneumococcal Vaccine revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

This report focuses on global and India Pneumococcal Vaccine market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Pneumococcal Vaccine will continue to grow rapidly in the future.

Global Pneumococcal Vaccine Scope and Market Size

Pneumococcal Vaccine market is segmented in regional and country, by players, by type and by end user. Companies, stakeholders, and other participants in the global Pneumococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by end user for the period 2018-2029.

For India market, this report focuses on the Pneumococcal Vaccine market size by players, by Type and by End User, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Pneumococcal Vaccine Market Report

Report Metric	Details
Report Name	and India Pneumococcal Vaccine Market
Forecasted market size in 2029	US$ 7780.4 million
CAGR	1.1%
Forecasted years	2023 - 2029
Segment by Type	PPSV 23 PCV 7/13 PCV 10
Segment by End User	Child Adult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, GSK, MSD, Sanofipasteur, CDIBP
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Pneumococcal Vaccine Market size in 2029?

Ans: The and India Pneumococcal Vaccine Market size in 2029 will be US$ 7780.4 million.

What is the Pfizer share in and India Pneumococcal Vaccine Market?

Ans: Pfizer is the leader of this industry with 84% market shares.

What is the and India Pneumococcal Vaccine Market share by region?

Ans: The second place is Europe, following North America with sales market share over 18%. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Pneumococcal Vaccine Market report?

Ans: The main players in the and India Pneumococcal Vaccine Market are Pfizer, GSK, MSD, Sanofipasteur, CDIBP

What are the Type segmentation covered in the and India Pneumococcal Vaccine Market report?

Ans: The Types covered in the and India Pneumococcal Vaccine Market report are PPSV 23, PCV 7/13, PCV 10

What are the End User segmentation covered in the and India Pneumococcal Vaccine Market report?

Ans: The End users covered in the and India Pneumococcal Vaccine Market report are Child, Adult

1 Study Coverage

1.1 Pneumococcal Vaccine Product Introduction

1.2 Global Pneumococcal Vaccine Outlook 2018 VS 2022 VS 2029

1.2.1 Global Pneumococcal Vaccine Sales in US$ Million for the Year 2018-2029

1.2.2 Global Pneumococcal Vaccine Sales in Volume for the Year 2018-2029

1.3 India Pneumococcal Vaccine Outlook 2018 VS 2022 VS 2029

1.3.1 India Pneumococcal Vaccine Sales in US$ Million for the Year 2018-2029

1.3.2 India Pneumococcal Vaccine Sales in Volume for the Year 2018-2029

1.4 Pneumococcal Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Pneumococcal Vaccine in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Pneumococcal Vaccine Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Pneumococcal Vaccine Market Dynamics

1.5.1 Pneumococcal Vaccine Industry Trends

1.5.2 Pneumococcal Vaccine Market Drivers

1.5.3 Pneumococcal Vaccine Market Challenges

1.5.4 Pneumococcal Vaccine Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Pneumococcal Vaccine by Type

2.1 Pneumococcal Vaccine Market Segment by Type

2.1.1 PPSV 23

2.1.2 PCV 7/13

2.1.3 PCV 10

2.2 Global Pneumococcal Vaccine Market Size by Type

2.2.1 Global Pneumococcal Vaccine Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Pneumococcal Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Pneumococcal Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Pneumococcal Vaccine Market Size by Type

2.3.1 India Pneumococcal Vaccine Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Pneumococcal Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Pneumococcal Vaccine Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Pneumococcal Vaccine by End User

3.1 Pneumococcal Vaccine Market Segment by End User

3.1.1 Child

3.1.2 Adult

3.2 Global Pneumococcal Vaccine Market Size by End User

3.2.1 Global Pneumococcal Vaccine Sales in Value, by End User (2018, 2022 & 2029)

3.2.2 Global Pneumococcal Vaccine Sales in Volume, by End User (2018, 2022 & 2029)

3.3.3 Global Pneumococcal Vaccine Average Selling Price (ASP) by End User (2018, 2022 & 2029)

3.3 India Pneumococcal Vaccine Market Size by End User

3.3.1 India Pneumococcal Vaccine Sales in Value, by End User (2018, 2022 & 2029)

3.3.2 India Pneumococcal Vaccine Sales in Volume, by End User (2018, 2022 & 2029)

3.3.3 India Pneumococcal Vaccine Average Selling Price (ASP) by End User (2018, 2022 & 2029)

4 Global Pneumococcal Vaccine Competitor Landscape by Company

4.1 Global Pneumococcal Vaccine Market Size by Company

4.1.1 Global Key Manufacturers of Pneumococcal Vaccine, Ranked by Revenue (2022)

4.1.2 Global Pneumococcal Vaccine Revenue by Manufacturer (2018-2023)

4.1.3 Global Pneumococcal Vaccine Sales by Manufacturer (2018-2023)

4.1.4 Global Pneumococcal Vaccine Price by Manufacturer (2018-2023)

4.2 Global Pneumococcal Vaccine Concentration Ratio (CR)

4.2.1 Pneumococcal Vaccine Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pneumococcal Vaccine in 2022

4.2.3 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Pneumococcal Vaccine, Product Offered and Application

4.5 Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Pneumococcal Vaccine Market Size by Company

4.7.1 Key Players of Pneumococcal Vaccine in India, Ranked by Revenue (2022)

4.7.2 India Pneumococcal Vaccine Revenue by Players (2018-2023)

4.7.3 India Pneumococcal Vaccine Sales by Players (2018-2023)

5 Global Pneumococcal Vaccine Market Size by Region

5.1 Global Pneumococcal Vaccine Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Pneumococcal Vaccine Market Size in Volume by Region (2018-2029)

5.2.1 Global Pneumococcal Vaccine Sales in Volume by Region: 2018-2023

5.2.2 Global Pneumococcal Vaccine Sales in Volume Forecast by Region (2024-2029)

5.3 Global Pneumococcal Vaccine Market Size in Value by Region (2018-2029)

5.3.1 Global Pneumococcal Vaccine Sales in Value by Region: 2018-2023

5.3.2 Global Pneumococcal Vaccine Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Pneumococcal Vaccine Market Size YoY Growth 2018-2029

6.2 Americas Pneumococcal Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Pneumococcal Vaccine Sales in Volume, by End User (2018, 2022 & 2029)

6.4 Americas Pneumococcal Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Pneumococcal Vaccine Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Pneumococcal Vaccine Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Pneumococcal Vaccine Market Size YoY Growth 2018-2029

7.2 EMEA Pneumococcal Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Pneumococcal Vaccine Sales in Volume, by End User (2018, 2022 & 2029)

7.4 EMEA Pneumococcal Vaccine Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Pneumococcal Vaccine Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Pneumococcal Vaccine Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Pneumococcal Vaccine Market Size YoY Growth 2018-2029

8.2 China Pneumococcal Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Pneumococcal Vaccine Sales in Volume, by End User (2018, 2022 & 2029)

9 APAC

9.1 APAC Pneumococcal Vaccine Market Size YoY Growth 2018-2029

9.2 APAC Pneumococcal Vaccine Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Pneumococcal Vaccine Sales in Volume, by End User (2018, 2022 & 2029)

9.4 APAC Pneumococcal Vaccine Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Pneumococcal Vaccine Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Pneumococcal Vaccine Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Pfizer

10.1.1 Pfizer Company Information

10.1.2 Pfizer Description and Business Overview

10.1.3 Pfizer Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Pfizer Pneumococcal Vaccine Products Offered

10.1.5 Pfizer Recent Development

10.2 GSK

10.2.1 GSK Company Information

10.2.2 GSK Description and Business Overview

10.2.3 GSK Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.2.4 GSK Pneumococcal Vaccine Products Offered

10.2.5 GSK Recent Development

10.3 MSD

10.3.1 MSD Company Information

10.3.2 MSD Description and Business Overview

10.3.3 MSD Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.3.4 MSD Pneumococcal Vaccine Products Offered

10.3.5 MSD Recent Development

10.4 Sanofipasteur

10.4.1 Sanofipasteur Company Information

10.4.2 Sanofipasteur Description and Business Overview

10.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Sanofipasteur Pneumococcal Vaccine Products Offered

10.4.5 Sanofipasteur Recent Development

10.5 CDIBP

10.5.1 CDIBP Company Information

10.5.2 CDIBP Description and Business Overview

10.5.3 CDIBP Pneumococcal Vaccine Sales, Revenue and Gross Margin (2018-2023)

10.5.4 CDIBP Pneumococcal Vaccine Products Offered

10.5.5 CDIBP Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Pneumococcal Vaccine Industry Chain Analysis

11.2 Pneumococcal Vaccine Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Pneumococcal Vaccine Production Mode & Process

11.4 Pneumococcal Vaccine Sales and Marketing

11.4.1 Pneumococcal Vaccine Sales Channels

11.4.2 Pneumococcal Vaccine Distributors

11.5 Pneumococcal Vaccine Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Pneumococcal Vaccine CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Pneumococcal Vaccine Market Trends

Table 3. Pneumococcal Vaccine Market Drivers

Table 4. Pneumococcal Vaccine Market Challenges

Table 5. Pneumococcal Vaccine Market Restraints

Table 6. Global Pneumococcal Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Pneumococcal Vaccine Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Pneumococcal Vaccine Sales Growth Rate (CAGR) by End User: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Pneumococcal Vaccine Sales Growth Rate (CAGR) by End User: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Pneumococcal Vaccine, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Pneumococcal Vaccine Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Pneumococcal Vaccine Revenue Share by Manufacturer, 2018-2023

Table 13. Global Pneumococcal Vaccine Sales by Manufacturer, (K Doses), 2018-2023

Table 14. Global Pneumococcal Vaccine Sales Share by Manufacturer, 2018-2023

Table 15. Global Pneumococcal Vaccine Price by Manufacturer (2018-2023) & (USD/Dose)

Table 16. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2022)

Table 18. Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Pneumococcal Vaccine, Product Offered and Application

Table 20. Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Pneumococcal Vaccine in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Pneumococcal Vaccine Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Pneumococcal Vaccine Revenue Share by Players, (2018-2023)

Table 25. India Pneumococcal Vaccine Sales by Players, (K Doses), (2018-2023)

Table 26. India Pneumococcal Vaccine Sales Share by Players, (2018-2023)

Table 27. Global Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Pneumococcal Vaccine Sales in Volume by Region (2018-2023) & (K Doses)

Table 29. Global Pneumococcal Vaccine Sales in Volume Forecast by Region (2024-2029) & (K Doses)

Table 30. Global Pneumococcal Vaccine Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Pneumococcal Vaccine Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Pneumococcal Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Pneumococcal Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Pneumococcal Vaccine Sales in Volume by Country (2018-2023) & (K Doses)

Table 36. Americas Pneumococcal Vaccine Sales in Volume by Country (2024-2029) & (K Doses)

Table 37. EMEA Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Pneumococcal Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Pneumococcal Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Pneumococcal Vaccine Sales in Volume by Country (2018-2023) & (K Doses)

Table 41. EMEA Pneumococcal Vaccine Sales in Volume by Country (2024-2029) & (K Doses)

Table 42. APAC Pneumococcal Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Pneumococcal Vaccine Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Pneumococcal Vaccine Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Pneumococcal Vaccine Sales in Volume by Country (2018-2023) & (K Doses)

Table 46. APAC Pneumococcal Vaccine Sales in Volume by Country (2024-2029) & (K Doses)

Table 47. Pfizer Company Information

Table 48. Pfizer Description and Business Overview

Table 49. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 50. Pfizer Pneumococcal Vaccine Product

Table 51. Pfizer Recent Development

Table 52. GSK Company Information

Table 53. GSK Description and Business Overview

Table 54. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 55. GSK Pneumococcal Vaccine Product

Table 56. GSK Recent Development

Table 57. MSD Company Information

Table 58. MSD Description and Business Overview

Table 59. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 60. MSD Pneumococcal Vaccine Product

Table 61. MSD Recent Development

Table 62. Sanofipasteur Company Information

Table 63. Sanofipasteur Description and Business Overview

Table 64. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 65. Sanofipasteur Pneumococcal Vaccine Product

Table 66. Sanofipasteur Recent Development

Table 67. CDIBP Company Information

Table 68. CDIBP Description and Business Overview

Table 69. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023)

Table 70. CDIBP Pneumococcal Vaccine Product

Table 71. CDIBP Recent Development

Table 72. Key Raw Materials Lists

Table 73. Raw Materials Key Suppliers Lists

Table 74. Pneumococcal Vaccine Customers List

Table 75. Pneumococcal Vaccine Distributors List

Table 76. Research Programs/Design for This Report

Table 77. Key Data Information from Secondary Sources

Table 78. Key Data Information from Primary Sources

List of Figures

Figure 1. Pneumococcal Vaccine Product Picture

Figure 2. Global Pneumococcal Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Pneumococcal Vaccine Market Size 2018-2029 (US$ Million)

Figure 4. Global Pneumococcal Vaccine Sales 2018-2029 (K Doses)

Figure 5. India Pneumococcal Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Pneumococcal Vaccine Market Size 2018-2029 (US$ Million)

Figure 7. India Pneumococcal Vaccine Sales 2018-2029 (K Doses)

Figure 8. India Pneumococcal Vaccine Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Pneumococcal Vaccine Market Share in Global, in Volume (K Doses) 2018-2029

Figure 10. Pneumococcal Vaccine Report Years Considered

Figure 11. Product Picture of PPSV 23

Figure 12. Product Picture of PCV 7/13

Figure 13. Product Picture of PCV 10

Figure 14. Global Pneumococcal Vaccine Market Share by Type in 2022 & 2029

Figure 15. Global Pneumococcal Vaccine Sales in Value by Type (2018-2029) & (US$ Million)

Figure 16. Global Pneumococcal Vaccine Sales Market Share in Value by Type (2018-2029)

Figure 17. Global Pneumococcal Vaccine Sales by Type (2018-2029) & (K Doses)

Figure 18. Global Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 19. Global Pneumococcal Vaccine Price by Type (2018-2029) & (USD/Dose)

Figure 20. India Pneumococcal Vaccine Market Share by Type in 2022 & 2029

Figure 21. India Pneumococcal Vaccine Sales in Value by Type (2018-2029) & (US$ Million)

Figure 22. India Pneumococcal Vaccine Sales Market Share in Value by Type (2018-2029)

Figure 23. India Pneumococcal Vaccine Sales by Type (2018-2029) & (K Doses)

Figure 24. India Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 25. India Pneumococcal Vaccine Price by Type (2018-2029) & (USD/Dose)

Figure 26. Product Picture of Child

Figure 27. Product Picture of Adult

Figure 28. Global Pneumococcal Vaccine Market Share by End User in 2022 & 2029

Figure 29. Global Pneumococcal Vaccine Sales in Value by End User (2018-2029) & (US$ Million)

Figure 30. Global Pneumococcal Vaccine Sales Market Share in Value by End User (2018-2029)

Figure 31. Global Pneumococcal Vaccine Sales by End User (2018-2029) & (K Doses)

Figure 32. Global Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2029)

Figure 33. Global Pneumococcal Vaccine Price by End User (2018-2029) & (USD/Dose)

Figure 34. India Pneumococcal Vaccine Market Share by End User in 2022 & 2029

Figure 35. India Pneumococcal Vaccine Sales in Value by End User (2018-2029) & (US$ Million)

Figure 36. India Pneumococcal Vaccine Sales Market Share in Value by End User (2018-2029)

Figure 37. India Pneumococcal Vaccine Sales by End User (2018-2029) & (K Doses)

Figure 38. India Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2029)

Figure 39. India Pneumococcal Vaccine Price by End User (2018-2029) & (USD/Dose)

Figure 40. Americas Pneumococcal Vaccine Sales in Volume Growth Rate 2018-2029 (K Doses)

Figure 41. Americas Pneumococcal Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 42. Americas Pneumococcal Vaccine Sales by Type (2018-2029) & (K Doses)

Figure 43. Americas Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 44. Americas Pneumococcal Vaccine Sales by End User (2018-2029) & (K Doses)

Figure 45. Americas Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2029)

Figure 46. United States Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 47. Canada Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 48. Mexico Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 49. Brazil Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 50. EMEA Pneumococcal Vaccine Sales in Volume Growth Rate 2018-2029 (K Doses)

Figure 51. EMEA Pneumococcal Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 52. EMEA Pneumococcal Vaccine Sales by Type (2018-2029) & (K Doses)

Figure 53. EMEA Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 54. EMEA Pneumococcal Vaccine Sales by End User (2018-2029) & (K Doses)

Figure 55. EMEA Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2029)

Figure 56. Europe Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 57. Middle East Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 58. Africa Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 59. China Pneumococcal Vaccine Sales in Volume Growth Rate 2018-2029 (K Doses)

Figure 60. China Pneumococcal Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 61. China Pneumococcal Vaccine Sales by Type (2018-2029) & (K Doses)

Figure 62. China Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 63. China Pneumococcal Vaccine Sales by End User (2018-2029) & (K Doses)

Figure 64. China Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2029)

Figure 65. APAC Pneumococcal Vaccine Sales in Volume Growth Rate 2018-2029 (K Doses)

Figure 66. APAC Pneumococcal Vaccine Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 67. APAC Pneumococcal Vaccine Sales by Type (2018-2029) & (K Doses)

Figure 68. APAC Pneumococcal Vaccine Sales Market Share in Volume by Type (2018-2029)

Figure 69. APAC Pneumococcal Vaccine Sales by End User (2018-2029) & (K Doses)

Figure 70. APAC Pneumococcal Vaccine Sales Market Share in Volume by End User (2018-2029)

Figure 71. Japan Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 72. South Korea Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 73. China Taiwan Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 74. Southeast Asia Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 75. India Pneumococcal Vaccine Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. Pneumococcal Vaccine Value Chain

Figure 77. Pneumococcal Vaccine Production Process

Figure 78. Channels of Distribution

Figure 79. Distributors Profiles

Figure 80. Bottom-up and Top-down Approaches for This Report

Figure 81. Data Triangulation

Figure 82. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions